A PHASE II STUDY OF LENALIDOMIDE AND RITUXIMAB (R²) COMBINATION IN PATIENTS WITH HIGH-RISK REFRACTORY/RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA

Hematological Oncology ◽

10.1002/hon.106_2631 ◽

2019 ◽

Vol 37 ◽

pp. 433-433

Author(s):

R. Bouabdallah ◽

C. Zemmour ◽

J. Schiano de Collela ◽

B. Slama ◽

J. Bladé ◽

...

Keyword(s):

High Risk ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text

A phase II study of R-COMP14 in elderly patients with high-risk diffuse large B-cell lymphoma (DLBCL) and moderate to high “life threat” impact cardiopathy.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.8058 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 8058-8058

Author(s):

G. Corazzelli ◽

F. Frigeri ◽

M. Arcamone ◽

A. Lucania ◽

G. Capobianco ◽

...

Keyword(s):

High Risk ◽

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Life Threat ◽

Download Full-text

PHASE II STUDY OF DURVALUMAB (ANTI-PD-L1) COMBINED WITH EITHER R-CHOP OR LENALIDOMIDE AND R-CHOP IN PREVIOUSLY UNTREATED, HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA

Hematological Oncology ◽

10.1002/hon.2440_1 ◽

2017 ◽

Vol 35 ◽

pp. 419-420 ◽

Author(s):

U. Jaeger ◽

N. Kalakonda ◽

H. Everaus ◽

P. Fustier ◽

J. Jaeger ◽

...

Keyword(s):

High Risk ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text

Dose‐intense chemoimmunotherapy plus radioimmunotherapy in high‐risk diffuse large B‐cell lymphoma and mantle cell lymphoma: a phase II study

British Journal of Haematology ◽

10.1111/bjh.15138 ◽

2018 ◽

Vol 184 (4) ◽

pp. 647-650

Author(s):

Kathryn E. Hudson ◽

David Rizzieri ◽

Samantha M. Thomas ◽

Thomas W. LeBlanc ◽

Zachary Powell ◽

...

Keyword(s):

High Risk ◽

B Cell ◽

Mantle Cell Lymphoma ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Mantle Cell ◽

Download Full-text

Clinical Efficacy and Epigenetic Biomarkers in a Phase II Study of Chidamide Plus R-CHOP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

SSRN Electronic Journal ◽

10.2139/ssrn.3532538 ◽

2020 ◽

Author(s):

Mu-Chen Zhang ◽

Peng-Peng Xu ◽

Ying Fang ◽

Li Wang ◽

Shu Cheng ◽

...

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Newly Diagnosed ◽

Epigenetic Biomarkers ◽

Large B Cell Lymphoma ◽

Download Full-text

LONG‐TERM ANALYSES FROM L‐MIND, A PHASE II STUDY OF TAFASITAMAB PLUS LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)

Hematological Oncology ◽

10.1002/hon.28_2879 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

J Duell ◽

K. J Maddocks ◽

E González‐Barca ◽

W Jurczak ◽

A. M Liberati ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text

Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B‐Cell Lymphoma Who Are Poor Candidates for R‐CHOP Chemotherapy

The Oncologist ◽

10.1634/theoncologist.2019-0286 ◽

2019 ◽

Vol 24 (8) ◽

pp. 1035 ◽

Author(s):

Ian W. Flinn ◽

Jack Erter ◽

Davey B. Daniel ◽

Joseph R. Mace ◽

Jesus G. Berdeja

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Newly Diagnosed ◽

Chop Chemotherapy ◽

Large B Cell Lymphoma ◽

Download Full-text

Preliminary results of a phase II study using response-adapted therapy for limited-stage diffuse large B-cell lymphoma based on interim PET/CT

Hematological Oncology ◽

10.1002/hon.2439_34 ◽

2017 ◽

Vol 35 ◽

pp. 301-302

Author(s):

F. Lv ◽

Z. Xia ◽

K. Xue ◽

Q. Zhang ◽

D. Ji ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Preliminary Results ◽

Interim Pet ◽

Large B Cell Lymphoma ◽

Pet Ct ◽

Download Full-text

ARGO: A RANDOMISED PHASE II STUDY OF ATEZOLIZUMAB WITH RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT CANDIDATES FOR HIGH-DOSE THERAPY

Hematological Oncology ◽

10.1002/hon.1_2632 ◽

2019 ◽

Vol 37 ◽

pp. 555-556

Author(s):

A.J. Davies ◽

O. Tansley Hancock ◽

T. Cummin ◽

J. Caddy ◽

L. Stanton ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Large B Cell Lymphoma ◽

Download Full-text

Japanese multicenter phase II study of CHOP followed by radiotherapy (RT) in stage I-II1 diffuse large B-cell lymphoma (DLBCL) of the stomach

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.6527 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6527-6527

Author(s):

S. Ishikura ◽

K. Tobinai ◽

A. Ohtsu ◽

S. Nakamura ◽

T. Yoshino ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Stage I ◽

Large B Cell Lymphoma ◽

Multicenter Phase ◽

Download Full-text

A phase II study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.8500 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 8500-8500 ◽

Author(s):

I. N. Micallef ◽

M. J. Maurer ◽

D. A. Nikcevich ◽

M. Cannon ◽

D. F. Moore ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text